8-Bromo-2-(methylthio)pyrido[4,3-d]pyrimidin-4(3H)-one

Catalog No. :
ACIRWF109
CAS No. :
1709905-39-4
Molecular Formula :
C8H6BrN3OS
Molecular Weight :
272.13

IUPAC Name:8-bromo-2-(methylthio)pyrido[4,3-d]pyrimidin-4(3H)-one

8-Bromo-2-(methylthio)pyrido[4,3-d]pyrimidin-4(3H)-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$325.00Login to see priceInquiryInquiry
100mg95%$476.00Login to see priceInquiryInquiry
250mg95%$673.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name8-Bromo-2-(methylthio)pyrido[4,3-d]pyrimidin-4(3H)-one
IUPAC Name8-bromo-2-(methylthio)pyrido[4,3-d]pyrimidin-4(3H)-one
Molecular FormulaC8H6BrN3OS
Molecular Weight272.13
SMILESO=C1NC(SC)=NC2C(Br)=CN=CC1=2
InChI KeySTUVZQRVMLUERX-UHFFFAOYSA-N
SynonymPyrido[4,3-d]pyrimidin-4(3H)-one, 8-bromo-2-(methylthio)-;8-Bromo-2-(methylthio)pyrido[4,3-d]pyrimidin-4(3H)-one;8-Bromo-2-(methylsulfanyl)-3H,4H-pyrido[4,3-d]pyrimidin-4-one
CAS No.1709905-39-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACIRWF109 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACFDIJ174 route compound structure diagram
    ACFDIJ17452834-08-9 In Stock
  4. Then
  5. ACIRWF109 route product structure diagram
    ACIRWF1091709905-39-4
Inquiry

2. ACIRWF109 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACFDIJ174 route compound structure diagram
    ACFDIJ17452834-08-9 In Stock
  4. Then
  5. ACIRWF109 route product structure diagram
    ACIRWF1091709905-39-4
Inquiry

Comments (0)